CEN:NZXContact Energy Limited Analysis
Data as of 2026-03-12 - not real-time
A$1.62
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
AUD 1.62 is trading below its 20‑day SMA (1.88), 50‑day SMA (1.95) and 200‑day SMA (2.06), signalling a bearish price environment. The 14‑day RSI of 24.6 places the stock in oversold territory, hinting at a possible short‑term rebound. However, the MACD line remains negative and its histogram is declining, reinforcing the current downtrend. Technical support is identified near 1.60, while resistance hovers around 2.09, framing a narrow trading range. Volume has been increasing, suggesting renewed market interest despite the weak price action.
Fundamentally, the company posts a PE of 11.5 versus an industry average of 32.6, indicating relative cheapness, yet its DCF‑derived fair value of 1.31 is well below the market price, implying overvaluation on intrinsic terms. The dividend yield of 6.3% is attractive, but a payout ratio of 75% combined with a debt‑to‑equity of 100% raises sustainability concerns. Revenue contracted 8% year‑over‑year and profit margin is negative, although the H1 2026 earnings call highlighted solid growth in asset‑management fees. Volatility is high at 41% over the past 30 days, but beta is modest (0.42), indicating limited systematic risk. Overall, the stock presents a mixed picture of value appeal tempered by leverage and earnings weakness.
Fundamentally, the company posts a PE of 11.5 versus an industry average of 32.6, indicating relative cheapness, yet its DCF‑derived fair value of 1.31 is well below the market price, implying overvaluation on intrinsic terms. The dividend yield of 6.3% is attractive, but a payout ratio of 75% combined with a debt‑to‑equity of 100% raises sustainability concerns. Revenue contracted 8% year‑over‑year and profit margin is negative, although the H1 2026 earnings call highlighted solid growth in asset‑management fees. Volatility is high at 41% over the past 30 days, but beta is modest (0.42), indicating limited systematic risk. Overall, the stock presents a mixed picture of value appeal tempered by leverage and earnings weakness.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Oversold RSI indicating potential rebound
- Price hovering just above identified support
- Increasing trading volume supporting short‑term interest
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Price remains below all major SMAs
- High leverage with debt‑to‑equity around 100%
- Dividend yield attractive but sustainability questionable
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Valuation gap between market price and DCF fair value
- Persistent earnings weakness and negative profit margin
- Sector exposure to real‑estate cycles and moderate regulatory risk
Key Metrics & Analysis
Financial Health
Revenue Growth-8.00%
Profit Margin-2.89%
P/E Ratio11.5
ROE7.56%
ROA4.33%
Debt/Equity100.38
P/B Ratio1.8
Op. Cash FlowA$145.3M
Free Cash FlowA$125.4M
Industry P/E32.6
Technical Analysis
TrendBearish
RSI24.7
SupportA$1.60
ResistanceA$2.09
MA 20A$1.88
MA 50A$1.95
MA 200A$2.06
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueA$1.31
Target PriceA$2.21
Upside/Downside37.12%
GradeFair
TypeValue
Dividend Yield6.32%
Risk Assessment
Beta0.42
Volatility41.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.